Over a year since Covid-19 shocked the world, the entire world continues to battle with the pandemic. It has affected every sector of society, and so health experts continue to think of ways to control the drastic effect of Covid somehow. Various health solutions were made and one of which is the use of Favipiravir (ฟาวิพิราเวียร์, term in Thai).
Favipiravir is promising in the treatment and management of Covid-19. It has an antiviral property, which is all the more useful in treating and managing Covid-19 and other viral-related conditions. People with Covid-19 are given Favipiravir as it helps decrease the viral load in the body. More so, it prevents the virus from spreading further and hastens the healing process.
Understanding Favipiravir and its usefulness in the treatment and management of Covid-19 patients
Favipiravir belongs to the antiviral class, and since Covid-19 is a viral condition, it only shows its usefulness in the treatment and management of viral-related conditions such as Covid-19. It is deemed useful in patients with mild to moderate Covid-19 infection. To maximize the health benefits of Favipiravir, it should only be given in patients with mild Covid-infection. It does not seem to work well in patients with severe Covid-19.
When using Favipiravir, it is important to begin the treatment at an early stage because a delay in treatment can slow down the efficacy of the drug. It could lead to worsening of symptoms such as severe cough, high fever, and difficulty of breathing. Viral conditions like Covid-19, if left untreated, can lead to organ failure, which is the primary reason why death in Covid-19 patients occurs. If you tested positive in Covid-19, it is a must to consult your doctor right away.
Starting Favipiravir has a positive impact on the PCR result. It helps stop the progression of the disease. It is made possible by inhibiting RdRP, an RNA dependent RNA polymerase, which is a viral enzyme. By inhibiting such action, the ability of the virus to replicate will be halted. In other words, it controls the multiplication of viruses, thereby preventing the spread of the virus in the body.
However, the use of such drugs for Covid-19 should be constantly monitored by a health care professional to prevent the possibility of side effects. Some of the side effects associated with Favipiravir use include diarrhea, a significant increase in the level of uric acid in the blood, and a noticeable decrease in white blood cell count. It can also increase the level of liver enzymes.
Conclusion
The use of Favipiravir has been a big help in treating and managing viral-related conditions, such as in the case of people suffering from Covid-19. Its use has shown a rapid increase in viral clearance and speeding up clinical improvement. In some countries like India, Favipiravir has been approved to use as a remedy for Covid-19. Its use in viral-related conditions leads to better clinical outcomes. However, to enhance the therapeutic effect of Favipiravir, it should be started right away, particularly in the early stage of the disease.
